Gilead Sciences, Inc. company logo
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$10.61B$963.00M-8.32%

Summary

Current Value
As of today, GILD annual cash & cash equivalents is $10.61B, down -8.32% on
Historical Performance
GILD annual cash & cash equivalents is up +54.64% over the past 3 years, up +28.37% over the past 5 years
All-Time High Comparison
GILD annual cash & cash equivalents is currently -65.74% below its historical high of $30.95B set on
3-Year Low Comparison
GILD annual cash & cash equivalents is +54.64% above its 3-year low of $6.86B reached on an earlier date
Sector Comparison
GILD annual cash & cash equivalents is higher than 99.23% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

GILD Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$10.61B-8.3%+54.6%+28.4%+405.3%
Quarterly Cash & Cash Equivalents$9.61B-16.9%+40.2%+16.4%+358.1%
Price$148.95+30.3%+87.1%+136.4%+663.3%
Annual Current Assets$19.89B+3.7%+37.7%+24.3%+248.4%
Annual Total Liabilities$36.40B-8.4%-13.3%-27.5%+565.4%
Annual Working Capital$8.07B+12.6%+151.8%+75.5%+148.9%
Annual Net Income$8.51B+1672.9%+86.4%+9461.8%+194.5%

Cash and Cash Equivalents Highs

GILD Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$11.57B-8.3%
5Y$11.57B-8.3%
All$30.95B-65.7%

Cash and Cash Equivalents Lows

GILD Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$6.86BN/A+54.6%
5Y$6.86B+54.6%
All$10.30M>+9999.0%

Cash and Cash Equivalents History

YearValueChange
$10.61B-8.3%
$11.57B+38.5%
$8.35B+21.8%
$6.86B-7.4%
$7.41B-10.4%
$8.26B-66.5%
$24.67B-20.3%
$30.95B+18.4%
$26.15B+119.8%
$11.90B-18.6%
$14.61B+44.2%
$10.13B+375.1%
$2.13B+14.5%
$1.86B-81.2%
$9.90B+371.7%
$2.10B+26.7%
$1.66B-7.4%
$1.79B+52.7%
YearValueChange
$1.17B+25.1%
$936.85M-59.7%
$2.32B+85.3%
$1.25B+77.4%
$707.00M-25.0%
$942.37M+61.7%
$582.85M+13.6%
$512.88M+74.2%
$294.39M+5.2%
$279.94M-13.1%
$322.30M+8.9%
$295.96M+90.1%
$155.66M+35.4%
$114.97M-17.5%
$139.35M+32.2%
$105.42M+923.5%
$10.30M-

FAQ

  • What is the current annual cash & cash equivalents of GILD?

    As of today, GILD annual cash & cash equivalents is $10.61B

  • What is 1-year change in GILD annual cash & cash equivalents?

    GILD annual cash & cash equivalents is down -8.32% year-over-year

  • What is 3-year change in GILD annual cash & cash equivalents?

    GILD annual cash & cash equivalents is up +54.64% over the past 3 years

  • How far is GILD annual cash & cash equivalents from its all-time high?

    GILD annual cash & cash equivalents is currently -65.74% below its historical high of $30.95B set on December 31, 2018

  • How does GILD annual cash & cash equivalents rank versus sector peers?

    GILD annual cash & cash equivalents is higher than 99.23% of companies in Healthcare sector

  • When is GILD next annual earnings release?

    As of today, the next annual earnings release for GILD has not been scheduled

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. GILD Official Website www.gilead.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/882095/000088209526000003/0000882095-26-000003-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/882095/000088209526000003/0000882095-26-000003-index.htm
  4. GILD Profile on Yahoo Finance finance.yahoo.com/quote/GILD
  5. GILD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gild